India to Australia: Atorvastatin Export Trade Route

The India to Australia Atorvastatin corridor is one of India's established pharmaceutical export routes, with 540 shipments documented worth a combined $15.6M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's atorvastatin manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $28.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with atorvastatin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 25.2%, placing it at rank #14 among India's top atorvastatin export destinations globally.

On the import side, key buyers of Indian atorvastatin in Australia include SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD. and 22 others. SUN PHARMA ANZ PTY LTD. is the single largest importer with 163 shipments valued at $3.6M USD.

India's atorvastatin exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 345 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , TENSHI KAIZEN PRIVATE LIMITED — together account for 91% of total trade value on this route. The average shipment value of $28.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo atorvastatin tab 40 mg: each film co and atorvastatin sz 80mg each film coated ta , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUN PHARMA ANZ PTY LTD. is the largest importer with 163 shipments worth $3.6M USD — representing 23% of all atorvastatin imports from India on this route. A total of 25 buyers are active on this corridor.